Literature DB >> 21140204

Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study.

Wegene Borena1, Tanja Stocks, Håkan Jonsson, Susanne Strohmaier, Gabriele Nagel, Tone Bjørge, Jonas Manjer, Göran Hallmans, Randi Selmer, Martin Almquist, Christel Häggström, Anders Engeland, Steinar Tretli, Hans Concin, Alexander Strasak, Pär Stattin, Hanno Ulmer.   

Abstract

OBJECTIVE: To assess the association between serum triglyceride levels and cancer risk.
METHODS: The metabolic syndrome and cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden; the current study included data on 257,585 men and 256,512 women. The mean age at study entry was 43.8 years for men and 44.2 years for women. The mean follow-up time was 13.4 years (SD = 8.5) for men and 11.9 years (SD = 7.2) for women. Excluding the first year of follow-up, 23,060 men and 15,686 women were diagnosed with cancer. Cox regression models were used to calculate relative risk (RR) of cancer for triglyceride levels in quintiles and as a continuous variable. RRs were corrected for random error by use of regression dilution ratio.
RESULTS: Relative risk for top quintile versus bottom quintile of triglycerides of overall cancer was 1.16 (95% confidence interval 1.06-1.26) in men and 1.15 (1.05-1.27) in women. For specific cancers, significant increases for top quintile versus bottom quintile of triglycerides among men were found for cancers of the colon, respiratory tract, the kidney, melanoma and thyroid and among women, for respiratory, cervical, and non-melanoma skin cancers.
CONCLUSION: Data from our study provided evidence for a possible role of serum triglycerides in cancer development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140204     DOI: 10.1007/s10552-010-9697-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  39 in total

1.  Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies.

Authors:  Nicholas Mitsiades; Kalliopi Pazaitou-Panayiotou; Konstantinos N Aronis; Hyun-Seuk Moon; John P Chamberland; Xiaowen Liu; Kalliope N Diakopoulos; Vasileios Kyttaris; Vasiliki Panagiotou; Geetha Mylvaganam; Sofia Tseleni-Balafouta; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-09-21       Impact factor: 5.958

Review 2.  Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.

Authors:  Jaroslav A Hubacek
Journal:  Gene       Date:  2016-08-02       Impact factor: 3.688

3.  Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Briseis Aschebrook-Kilfoy; Mona M Sabra; Alina Brenner; Steven C Moore; Elaine Ron; Arthur Schatzkin; Albert Hollenbeck; Mary H Ward
Journal:  Thyroid       Date:  2011-07-18       Impact factor: 6.568

Review 4.  Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Concetta Rafaniello; Demosthenes B Panagiotakos; Dario Giugliano
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

5.  Daily Intake of High-Fat Diet with Lysophosphatidic Acid-Rich Soybean Phospholipids Augments Colon Tumorigenesis in Kyoto Apc Delta Rats.

Authors:  Toshihiko Tsutsumi; Manami Inoue; Yoko Okamoto; Akira Ishihara; Akira Tokumura
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

6.  Metabolic syndrome and colorectal neoplasms: An ominous association.

Authors:  Daniel Trabulo; Suzane Ribeiro; Cláudio Martins; Cristina Teixeira; Cláudia Cardoso; João Mangualde; Ricardo Freire; Élia Gamito; Ana L Alves; Fátima Augusto; Ana P Oliveira; Isabelle Cremers
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

7.  Fatty acid synthase/oxidized low-density lipoprotein as metabolic oncogenes linking obesity to colon cancer via NF-kappa B in Egyptians.

Authors:  Walaa Arafa Keshk; Doaa Hussein Zineldeen; Rania E L-sayed Wasfy; Osama Helmy El-Khadrawy
Journal:  Med Oncol       Date:  2014-08-31       Impact factor: 3.064

8.  Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population.

Authors:  Eribeth K Penaranda; Navkiran Shokar; Melchor Ortiz
Journal:  ISRN Oncol       Date:  2013-01-21

9.  Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan.

Authors:  Wuan-Szu Wang; Mark L Wahlqvist; Chih-Cheng Hsu; Hsing-Yi Chang; Wan-Chi Chang; Chu-Chih Chen
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

10.  Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study.

Authors:  Wahyu Wulaningsih; Hans Garmo; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.